‘Pfizer Inc. said 2006 net income will rise 40 percent as the world’s largest drugmaker enters the second year of a $4 billion cost-cutting plan.
Earnings this year will rise to $11.4 billion to $11.7 billion, or $1.52 to $1.56 a share, from $8.09 billion, or $1.09, in 2005, Pfizer said today in a statement as […]
‘Pfizer (PFE:NYSE - news - research - Cramer’s Take) said Friday that 2006 will yield flat sales and slightly lower earnings per share, but the drug giant indicated that its top-line growth should resume in 2007 as new drugs more than offset the loss of patents on its existing medications.
The company is looking for what […]
‘Analysts had been optimistic about the potential of using RFID technology to track pharmaceuticals, thereby curbing theft and counterfeiting while encouraging supply chain efficiency.
In fact, last year technology market research firm ABI Research estimated that the shipments of life sciences RFID transponders would more than triple by the end of this year.
But new state legislation […]
‘Diabetes is fast becoming a serious global problem. No surprise, then, that a lot of folks cheered after learning that a new drug option — the first inhaled form of insulin — will soon hit pharmacy shelves.
The drug, called Exubera, provides an option for diabetes patients who are supposed to inject themselves with insulin three […]
‘GlaxoSmithKline sought to reassure investors yesterday by announcing it would file its potential blockbuster cervical cancer vaccine, Cervarix, for approval in the US before the end of the year.
The news came after the British pharmaceuticals giant unveiled its best annual performance since 2000 when it was formed from the merger of SmithKline Beecham and Glaxo […]
‘Pfizer Inc. has filed a patent infringement suit against generic drug makers Teva Pharmaceutical Industries Ltd. and Sandoz Inc. concerning generic versions of the antibiotic Zithromax.
Representatives from Sandoz, based in Princeton, N.J., and Teva, based in Israel, couldn’t immediately be reached for comment.
In a press release Wednesday, Pfizer also said it filed a petition with […]
‘Pharmaceuticals giant GlaxoSmithKline posted a 13-percent jump in annual pre-tax profits and said it should start clinical trials within weeks of a vaccine against bird flu.
GSK said 2005 pre-tax profits rose to 6.732 billion pounds (9.805 billion euros, 11.724 billion dollars), while revenue increased 7.0 percent to 21.66 billion pounds from the previous year.’
Read more […]
‘Prospects for a new class of effective AIDS medicines soared Wednesday when two drugmakers reported surprisingly strong results from clinical trials of their experimental pills.
The drugs, known as integrase inhibitors, performed in small trials as well or better than most of the antiviral medicines that serve as the mainstays of current therapies, AIDS experts said.’
Read […]
‘Twenty-five people died and 54 more suffered serious cardiovascular problems after taking drugs to treat attention deficit hyperactivity disorder between 1999 and 2003, the government says.
Children accounted for 19 of the deaths and 26 of the cases of non-fatal cardiovascular problems, including heart attack, stroke, hypertension, palpitations and arrhythmia, according to a Food and Drug […]
‘Lawyers switched legal tactics for the retrial of the first federal Vioxx case, working to convince jurors that manufacturer Merck & Co. ignored safety in favor of sales, rather than opening with medical testimony.
That approach is much closer to an earlier trial in a Texas state court, in which jurors decided Merck should pay $253.4 […]